Biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence approaches
| Website | http://www.bioxceltherapeutics.com |
| Ticker | NASDAQ:BTAI |
| Employees | 181 (68 on RocketReach) |
| Founded | 2017 |
| Address | 555 Long Wharf Dr 12th floor, New Haven, Connecticut 06511, US |
| Phone | (203) 643-8060 |
| Technologies |
JavaScript
,
HTML
,
PHP
+47 more
(view full list)
|
| Industry | Biotechnology, Science and Engineering |
| Keywords | Neuroscience, Biopharmaceutical, Immuno Oncology, Therapeutics, Neurological Disorders, Drug Discovery, Drug Development, Biotechnology, Brain Health, Immunotherapy, Pharmaceutical Research, Ai In Medicine, Clinical Trials, Oncology, Biologics, Cancer Treatment, Artificial Intelligence, Precision Medicine, Medicine |
| Competitors | BridgeBio, Zymeworks Inc., Alder BioPharmaceuticals, Inc., Marinus Pharma, Cara Therapeutics, Rigel Pharmaceuticals Inc., Iovance Biotherapeutics, Inc., NantKwest, Axovant Sciences Ltd, Medallion Therapeutics, Inc. +37 more (view full list) |
Looking for a particular BioXcel Therapeutics, Inc. employee's phone or email?
Michael de Vivo is the Vice President of Neuroscience of BioXcel Therapeutics, Inc..
68 people are employed at BioXcel Therapeutics, Inc..
BioXcel Therapeutics, Inc. is based in New Haven, Connecticut.